MedPath

Amphetamine Sulfate

Amphetamine Sulfate Tablets, USP CII

Approved
Approval ID

26dbad66-13c4-4906-88b3-ab7ee191466c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 16, 2023

Manufacturers
FDA

Granules Pharmaceuticals Inc.

DUNS: 079825711

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Amphetamine Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70010-041
Application NumberANDA212619
Product Classification
M
Marketing Category
C73584
G
Generic Name
Amphetamine Sulfate
Product Specifications
Route of AdministrationORAL
Effective DateOctober 16, 2023
FDA Product Classification

INGREDIENTS (6)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
AMPHETAMINE SULFATEActive
Quantity: 10 mg in 1 1
Code: 6DPV8NK46S
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

Amphetamine Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70010-040
Application NumberANDA212619
Product Classification
M
Marketing Category
C73584
G
Generic Name
Amphetamine Sulfate
Product Specifications
Route of AdministrationORAL
Effective DateOctober 16, 2023
FDA Product Classification

INGREDIENTS (5)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
AMPHETAMINE SULFATEActive
Quantity: 5 mg in 1 1
Code: 6DPV8NK46S
Classification: ACTIB
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Amphetamine Sulfate - FDA Drug Approval Details